日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

LINC01929 mediates breast cancer immunosuppression and is an immunotherapy target.

LINC01929介导乳腺癌免疫抑制,是免疫治疗靶点。

Venkatesh Jaganathan, Wasson Marie-Claire D, Arun Raj Pranap, Cahill Hannah F, Walker Olivia L, Dean Cheryl A, Fernando Wasundara, MacLean Maya R, McLean Meghan E, Khan Bakhmala, Kruth Perryn S, Sultonova Mukhayyo, Nersesian Sarah, Lee Stacey N, Longjohn Modeline N, Hughes Christopher S, Belbin Thomas J, Gaston Daniel, Paulo Joao A, Knapp Gregory C, Bethune Gillian, Gujar Shashi, Boudreau Jeanette E, Murphy J Patrick, Marcato Paola

THSD4 is a novel mediator of T cell exclusion and anti-PD-1 resistance in hormone receptor-positive breast cancer

THSD4是激素受体阳性乳腺癌中T细胞排斥和抗PD-1耐药性的新型介质

Walker, Olivia L; Wasson, Marie-Claire D; Kumar, Vishnupriyan; Nersesian, Sarah; Venkatesh, Jaganathan; Vijayan, Vishnu V; Coates, Lily; Fernando, Wasundara; Arun, Raj Pranap; Cahill, Hannah F; Baker, Elizabeth; Dahn, Margaret L; Slauenwhite, Drew; Cruickshank, Brianne M; Barnes, Penelope; Longjohn, Modeline N; Belbin, Thomas James; Gaston, Daniel; Knapp, Gregory C; Melvin, Jennifer; Gujar, Shashi; Boudreau, Jeanette E; Bethune, Gillian; Marcato, Paola